Mckinnell Henry A
SEC-identified person · CIK 1174453 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Chemocentryx, Inc. CCXI | Director | filed 2016–2022 |
| Moodys Corp /DE/ MCO | Director | filed 2006–2021 |
| Federal Street Acquisition Corp. FSAC | Director | filed 2017–2019 |
| Viewray, Inc. VRAY | Director | filed 2016–2019 |
| Emmaus Life Sciences, INC. [NONE] | Director | filed 2011–2014 |
| Optimer Pharmaceuticals INC OPTR | Director · CEO and Chairman of the Board | filed 2011–2013 |
| Angiotech Pharmaceuticals INC ANPMF | Director | filed 2008–2009 |
| Exxon Mobil Corp xom | Director | filed 2006–2007 |
| Pfizer INC pfe | Director · Chairman and CEO | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.